Equities

Cutera Inc

Cutera Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.389
  • Today's Change0.000 / 0.13%
  • Shares traded669.99k
  • 1 Year change-76.85%
  • Beta1.2388
Data delayed at least 15 minutes, as of Nov 11 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Cutera, Inc. develops, manufactures, distributes, and markets energy-based product platforms for medical practitioners, enabling them to offer treatments to their customers. The Company distributes third-party manufactured skincare products and secret systems and consumables. Its system platforms include AviClear, enlighten, excel, truSculpt, Secret PRO, Secret RF, and xeo. The Company’s Cutera Core segment consists of the Company’s systems, consumables, skincare, and service businesses. The Cutera Core segment develops, distributes and manufactures energy-based systems for medical practitioners in addition to distributing third-party manufactured skincare products in Japan. The Company’s AviClear segment consists of the AviClear business. The Company’s acne solution, AviClear, is a prescription-free, drug-free laser treatment for the treatment of mild to severe acne. Its products include CUTERA, ACUTIP 500, AVITM, AVI360, AVIANALYTICSTM, AVICARE COOLGLIDE, and more.

  • Revenue in USD (TTM)169.19m
  • Net income in USD-148.97m
  • Incorporated1998
  • Employees430.00
  • Location
    Cutera Inc3240 Bayshore BlvdBRISBANE 94005-1021United StatesUSA
  • Phone+1 (415) 657-5500
  • Fax+1 (415) 330-2444
  • Websitehttps://www.cutera.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Bionoid Pharma Inc0.001.35m5.40m13.000.0882--3.99--1.131.130.00-0.1744-----------506.64--------------327.24---------31.55--26.01--
Aethlon Medical, Inc.0.00-11.50m5.62m14.00--0.6447-----3.87-3.870.000.62510.00----0.00-84.49-76.25-98.84-85.78-------2,246.87----0.00---100.00---1.43------
Agape ATP Corp1.38m-2.45m5.73m21.00--1.78--4.16-0.6396-0.63960.35990.83660.44648.2536.6665,621.91-78.78---111.56--64.23---176.47--4.66--0.0225---22.92---24.61------
Caduceus Software Systems Corp0.00-117.60k5.78m0.00---------0.0004-0.00040.00-0.00040.00-------402.19-11,090.31---------------76.88---------20,519.89------
Optimus Healthcare Services Inc1.89m-7.16m5.94m12.00------3.15-0.1744-0.17440.0454-0.18891.26--3.67157,291.70-477.28------85.93---379.51-----5.42----22.88---3.51------
Bioelectronics Corp1.61m-289.82k6.18m9.00------3.84-0.00002-0.000020.00007-0.00066.329.2014.53---113.86-383.59----49.4351.48-18.01-143.480.0099-0.4909----94.01-5.0975.01------
Biomerica Inc5.51m-6.16m6.56m63.00--1.23--1.19-0.3663-0.36630.32740.31780.52232.633.6987,412.70-58.44-44.68-71.68-51.738.8114.11-111.89-63.822.09--0.00--1.420.810916.27---7.64--
Dalrada Financial Corporation32.16m-21.34m6.79m0.00--0.7687--0.2111-0.2388-0.23880.35730.0911.098.863.37---75.10-80.63-239.06--30.1139.23-68.78-63.941.24-21.540.3452--54.35---43.94------
Neurometrix Inc4.38m-7.94m7.54m26.00--0.4333--1.72-5.50-5.502.918.580.21021.158.53168,600.80-38.06-23.24-40.80-27.2660.1959.17-181.03-48.8810.71--0.00---28.52-18.18-47.84--5.03--
Biotricity Inc12.24m-18.28m7.63m55.00------0.6235-1.74-1.741.18-1.272.121.678.08222,624.00-248.61-269.25----71.8958.93-117.41-258.940.106-0.6408----25.1597.8223.57------
Cutera Inc169.19m-148.97m7.82m430.00------0.0462-7.46-7.468.46-10.730.45722.083.86393,460.50-40.25-22.00-51.64-30.728.1847.63-88.05-27.242.17-31.342.05---15.865.47-97.76--85.87--
Precipio Inc16.72m-3.83m9.04m51.00--0.7399--0.5407-2.68-2.6811.738.240.908917.1216.80327,843.10-20.82-44.98-27.94-58.6839.0828.80-22.90-118.070.590-192.590.0517--61.4639.6252.04--5.37--
Sigyn Therapeutics Inc0.00-3.70m9.15m5.00---------3.08-3.080.00-2.910.00----0.00-1,085.72-493.15-----------10,223.960.0247-2.09---------41.51------
ALR Technologies Inc9.49k-8.00m9.21m6.00------970.95-0.0147-0.01470.00002-0.04760.0358----1,581.67-3,015.28-12,861.64----62.49---84,283.24-406,011.30---0.8626---------42.72------
Applied DNA Sciences Inc3.40m-7.52m9.64m53.00--0.1587--2.84-11.86-11.862.181.200.20926.835.6864,114.15-45.51-88.57-55.20-121.9125.0444.35-217.48-113.263.76--0.00---26.4327.92-18.73--33.80--
T2 Biosystems Inc7.16m-48.26m10.14m113.00------1.41-10.70-10.701.09-0.33910.24352.825.4163,398.23-164.01-106.01---253.03-86.96-12.60-673.67-317.930.359-12.442.00---67.75-7.2919.66---20.19--
Data as of Nov 11 2024. Currency figures normalised to Cutera Inc's reporting currency: US Dollar USD

Institutional shareholders

32.04%Per cent of shares held by top holders
HolderShares% Held
RTW Investments LPas of 30 Jun 20241.33m6.62%
Pura Vida Investments LLCas of 30 Jun 20241.17m5.79%
The Vanguard Group, Inc.as of 30 Sep 2024914.63k4.54%
Millennium Management LLCas of 30 Jun 2024669.95k3.33%
Stifel Nicolaus & Co., Inc. (Investment Management)as of 30 Jun 2024498.58k2.48%
Hawk Ridge Capital Management LPas of 30 Jun 2024444.91k2.21%
BlackRock Fund Advisorsas of 30 Jun 2024384.57k1.91%
GAMCO Asset Management, Inc.as of 30 Aug 2024377.30k1.88%
Gabelli Funds LLCas of 30 Aug 2024334.60k1.66%
Boothbay Fund Management LLCas of 30 Jun 2024327.07k1.63%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.